The estimated Net Worth of Healthcare Partners Fund 2,... is at least $10.8 Million dollars as of 17 August 2022. Healthcare 2 owns over 500,000 units of TELA Bio stock worth over $10,839,072 and over the last 5 years Healthcare sold TELA stock worth over $0.
Healthcare has made over 65 trades of the TELA Bio stock since 2020, according to the Form 4 filled with the SEC. Most recently Healthcare bought 500,000 units of TELA stock worth $4,000,000 on 17 August 2022.
The largest trade Healthcare's ever made was buying 759,808 units of TELA Bio stock on 22 February 2022 worth over $8,927,744. On average, Healthcare trades about 45,484 units every 13 days since 2020. As of 17 August 2022 Healthcare still owns at least 4,105,709 units of TELA Bio stock.
You can see the complete history of Healthcare 2 stock trades at the bottom of the page.
Over the last 5 years, insiders at TELA Bio have traded over $4,222,376 worth of TELA Bio stock and bought 4,343,227 units worth $46,898,981 . The most active insiders traders include Management Inc. Opaleye, Investments, Lpwong Roderic..., and Advisors Llc Orbi Med Capit.... On average, TELA Bio executives and independent directors trade stock every 18 days with the average trade being worth of $139,070. The most recent stock trade was executed by Advisors Llc Orbi Med Capit... on 28 June 2024, trading 428,300 units of TELA stock currently worth $2,021,576.
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
TELA Bio executives and other stock owners filed with the SEC include: